• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:陈园,李涛,邓斌,丁彦郅,邹龙.苦杏仁苷领域的文献计量学研究及其可视化分析[J].药学研究,2024,43(11):1059-1066[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2509次   下载 2470次 本文二维码信息
码上扫一扫!
苦杏仁苷领域的文献计量学研究及其可视化分析
陈园,李涛,邓斌,丁彦郅,邹龙
字体:加大+|默认|缩小-
(湖南中医药大学药学院,湖南 长沙 410208)
摘要:
目的 基于文献计量学方法对苦杏仁苷的研究领域的现状与热点进行分析与总结。方法 通过检索中国知网(CNKI)、维普(VIP)、万方(Wanfang)和Web of Science数据库中苦杏仁苷的相关文献,利用NoteExperss软件剔除重复数据,采用文献计量学软件CiteSpace、VOSviewer进行分析以及利用Excel2024和Origin2022软件作图,对2000年1月1日—2024年2月4日已发表的苦杏仁苷的文献发文量、国家、机构、作者、期刊以及关键词进行文献可视化分析。结果 经过筛选,最终纳入中文文献1 456 篇,英文文献534 篇,文献发文量呈波动式增长,研究在近年来火热;中国为苦杏仁苷领域发文量最多的国家,占主导地位;英文文献的发文量在2016年开始出现明显增长;王振中和张庆安等为中、英文文献发表较多的作者;中、英文献发表最多的机构分别为南京中医药大学和Egyptian Knowledge Bank,然而各国和机构之间的合作仍需要加强。结论 苦杏仁苷的质量标准、药理作用及其作用机制是未来研究的前沿内容,对苦杏仁苷的深层次研究可以有助于揭示其更为复杂的药理作用及作用机制,从而更好地指导其在临床上的应用。此外,对苦杏仁苷的研究还有助于开发更安全、更有效的药物,并为相关疾病的治疗提供新的思路和方法。
关键词:  苦杏仁苷  文献计量学  可视化分析  抗癌  药理作用  质量标准
DOI:10.13506/j.cnki.jpr.2024.11.004
基金项目:湖南省研究生科研创新课题项目(No.CX20230830)
出版日期:2024-11-25
Bibliometric research and visual analysis in the field of amygdalin
CHEN Yuan,LI Tao,DENG Bin,DING Yanzhi,ZOU Long
(School of Pharmacy, Hunan University of Chinese Medicine,Changsha 410208, China)
Abstract:
Objective The current status and hotspots in the research field of bitter amygdalin are analyzed and summarized based on bibliometric methods.Methods The literature on bitter almond glycosides was searched in the databases of CNKI, Vip , Wanfang and Web of Science, and the duplicates were eliminated by using NoteExperss software, analyzed by using the bibliometric software CiteSpace, VOSviewer, and graphically analyzed by using the software of Excel2024 and Origin2022 software for graphing, and literature visualization of the published literature on bitter amygdalin from January 1, 2000 to February 4, 2024 in terms of the number of publications, countries, institutions, authors, journals, and keywords.Results After screening, 1 456 articles in Chinese and 534 articles in English were finally included, and the amount of literature published showed fluctuating growth, and the research has been hot in recent years; China is the country with the most articles in the field of bitter amygdalin, which dominates the field; the amount of articles in English began to show a significant growth in 2016; Wang Zhenzhong and Zhang Qing'an, etc. are the authors who have published more in Chinese and English; the institutions that have published most in Chinese and English are Nanjing University of Chinese Medicine and Egyptian Knowledge Bank, respectively; however, the cooperation between countries and institutions still needs to be strengthened. institutions are Nanjing University of Traditional Chinese Medicine and Egyptian Knowledge Bank, respectively; however, the cooperation between countries and institutions still needs to be strengthened.Conclusion The quality standards, pharmacological effects and mechanism of action of amygdalin are the frontiers of future research, and in-depth studies on amygdalin can help to reveal its more complex pharmacological effects and mechanism of action, so as to better guide its application in clinical practice. In addition, the study of bitter amygdalin can also help to develop safer and more effective drugs and provide new ideas and methods for the treatment of related diseases.
Key words:  Amygdalin  Bibliometrics  Visual analysis  Anti-cancer  Bharmacological effect  Quality Standard
今日访问量:2772    总访问量:55339354
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司